Skip to main content

Research and statistics

Skip to results
526 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Outlines the quality and methodology information (QMI) relevant to the respiratory syncytial virus (RSV) official statistics releases.

  • Cumulative vaccine uptake data for the childhood seasonal influenza programme in England, 2025 to 2026 data.

  • Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England.

  • Rapid systematic review on effectiveness of additional IPC measures to precent spread of C. difficile in periods of high prevalence in health and social care settings.

  • A rapid systematic review on the effectiveness of isolation strategies for people with C. difficile.

  • Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequency of C. difficile infections (CDI).

  • Trends in voluntary reports of Enterococcus spp. by age, sex and geographical distribution in England.

  • Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in England.

  • This annual report covers surgical site infection (SSI) data collected by NHS hospitals and independent sector NHS treatment centres.

  • Voluntary surveillance of paediatric bacteraemia in England.

  • Annual reports and data tables showing the frequency of bloodstream infections in critical care units in England, the microbes that cause them, and linked factors.

  • Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.

  • Voluntary surveillance of streptococcal bacteraemia in England.

  • Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection (CDI) reported by independent sector healthcare organisations, with accompanying commentary. Official statistics …

  • Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).

  • Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

  • Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.

  • Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).